Literature DB >> 11907238

Expression of simian immunodeficiency virus nef in immune cells of transgenic mice leads to a severe AIDS-like disease.

Marie-Chantal Simard1, Pavel Chrobak, Denis G Kay, Zaher Hanna, Serge Jothy, Paul Jolicoeur.   

Abstract

In order to study the functions of simian immunodeficiency virus (SIV) Nef in vivo in a small-animal model, we constructed transgenic (Tg) mice expressing the SIV(mac)239 nef gene in the natural target cells of the virus under the control of the human CD4 gene promoter (CD4C). These CD4C/SHIV-nef(SIV) Tg mice develop a severe AIDS-like disease, with manifestations including premature death, failure to thrive or weight loss, wasting, thymic atrophy, an especially low number of peripheral CD8+ T cells as well as a low number of peripheral CD4+ T cells, diarrhea, splenomegaly, and kidney (interstitial nephritis, segmental glomerulosclerosis), lung (lymphocytic interstitial pneumonitis), and heart disease. In addition, these Tg mice fail to mount a class-switched antibody response after immunization with ovalbumin, they produce anti-DNA autoantibodies, and some of them develop Pneumocystis carinii lung infections. All these results suggest a generalized Nef-induced immunodeficiency. The low numbers of peripheral CD8+ and CD4+ T cells are likely to reflect a thymic defect and may be similar to the DiGeorge-like "thymic defect" immunophenotype described for a subgroup of human immunodeficiency virus type 1-infected children. Therefore, it appears that SIV Nef alone expressed in mice, in appropriate cell types and at sufficient levels, can elicit many of the phenotypes of simian and human AIDS. These Tg mice should be instrumental in studying the pathogenesis of SIV Nef-induced phenotypes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11907238      PMCID: PMC136064          DOI: 10.1128/jvi.76.8.3981-3995.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  70 in total

Review 1.  HIV nef: the mother of all evil?

Authors:  F Peter
Journal:  Immunity       Date:  1998-10       Impact factor: 31.745

2.  Association of simian immunodeficiency virus Nef with the T-cell receptor (TCR) zeta chain leads to TCR down-modulation.

Authors:  I Bell; C Ashman; J Maughan; E Hooker; F Cook; T A Reinhart
Journal:  J Gen Virol       Date:  1998-11       Impact factor: 3.891

Review 3.  The role of Nef in the replication cycle of the human and simian immunodeficiency viruses.

Authors:  B R Cullen
Journal:  Virology       Date:  1994-11-15       Impact factor: 3.616

4.  Human immunodeficiency virus type 1 Nef-induced down-modulation of CD4 is due to rapid internalization and degradation of surface CD4.

Authors:  S S Rhee; J W Marsh
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

5.  Development of malabsorption and nutritional complications in simian immunodeficiency virus-infected rhesus macaques.

Authors:  J D Stone; C C Heise; C J Miller; C H Halsted; S Dandekar
Journal:  AIDS       Date:  1994-09       Impact factor: 4.177

6.  Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice.

Authors:  Z Hanna; D G Kay; N Rebai; A Guimond; S Jothy; P Jolicoeur
Journal:  Cell       Date:  1998-10-16       Impact factor: 41.582

7.  Construction and in vitro properties of SIVmac mutants with deletions in "nonessential" genes.

Authors:  J S Gibbs; D A Regier; R C Desrosiers
Journal:  AIDS Res Hum Retroviruses       Date:  1994-05       Impact factor: 2.205

8.  Pathogenesis of simian immunodeficiency virus pneumonia: an immunopathological response to virus.

Authors:  J L Mankowski; D L Carter; J P Spelman; M L Nealen; K R Maughan; L M Kirstein; P J Didier; R J Adams; M Murphey-Corb; M C Zink
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

9.  Zeta chain of the T-cell receptor interacts with nef of simian immunodeficiency virus and human immunodeficiency virus type 2.

Authors:  A Y Howe; J U Jung; R C Desrosiers
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

10.  A pathogenic threshold of virus load defined in simian immunodeficiency virus- or simian-human immunodeficiency virus-infected macaques.

Authors:  P Ten Haaft; B Verstrepen; K Uberla; B Rosenwirth; J Heeney
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

View more
  20 in total

Review 1.  HIV-1 Nef control of cell signalling molecules: multiple strategies to promote virus replication.

Authors:  Alison L Greenway; Gavan Holloway; Dale A McPhee; Phoebe Ellis; Alyssa Cornall; Michael Lidman
Journal:  J Biosci       Date:  2003-04       Impact factor: 1.826

2.  Extracellular Nef protein targets CD4+ T cells for apoptosis by interacting with CXCR4 surface receptors.

Authors:  Cleve O James; Ming-Bo Huang; Mafuz Khan; Minerva Garcia-Barrio; Michael D Powell; Vincent C Bond
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

3.  Characterization of Nef-CXCR4 interactions important for apoptosis induction.

Authors:  Ming-Bo Huang; Ling Ling Jin; Cleve O James; Mahfuz Khan; Michael D Powell; Vincent C Bond
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

4.  Neutron reflectometry study of the conformation of HIV Nef bound to lipid membranes.

Authors:  Michael S Kent; Jaclyn K Murton; Darryl Y Sasaki; Sushil Satija; Bulent Akgun; Hirsh Nanda; Joseph E Curtis; Jaroslaw Majewski; Christopher R Morgan; John R Engen
Journal:  Biophys J       Date:  2010-09-22       Impact factor: 4.033

5.  Validation of a novel secretion modification region (SMR) of HIV-1 Nef using cohort sequence analysis and molecular modeling.

Authors:  Patrick E Campbell; Olexandr Isayev; Syed A Ali; William W Roth; Ming-Bo Huang; Michael D Powell; Jerzy Leszczynski; Vincent C Bond
Journal:  J Mol Model       Date:  2012-05-30       Impact factor: 1.810

6.  Secretion modification region-derived peptide disrupts HIV-1 Nef's interaction with mortalin and blocks virus and Nef exosome release.

Authors:  Martin N Shelton; Ming-Bo Huang; Syed A Ali; Michael D Powell; Vincent C Bond
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

Review 7.  Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.

Authors:  Louis de Repentigny; Daniel Lewandowski; Paul Jolicoeur
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

8.  Reduction of Stat3 activity attenuates HIV-induced kidney injury.

Authors:  Xiaobei Feng; Ting-Chi Lu; Peter Y Chuang; Wei Fang; Krishna Ratnam; Huabao Xiong; Xinshou Ouyang; Yuhong Shen; David E Levy; Deborah Hyink; Mary Klotman; Vivette D'Agati; Ravi Iyengar; Paul E Klotman; John C He
Journal:  J Am Soc Nephrol       Date:  2009-07-16       Impact factor: 10.121

Review 9.  APOL1 Renal Risk Variants: Fertile Soil for HIV-Associated Nephropathy.

Authors:  Jeffrey B Kopp; Jurgen Heymann; Cheryl A Winkler
Journal:  Semin Nephrol       Date:  2017-11       Impact factor: 5.299

10.  Cardiac disease in transgenic mice expressing human immunodeficiency virus-1 nef in cells of the immune system.

Authors:  Denis G Kay; Ping Yue; Zaher Hanna; Serge Jothy; Etienne Tremblay; Paul Jolicoeur
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.